Q2 2024 |
39 |
$818M |
+$2.21M |
-$189M |
-$187M |
INSM, BMRN, FOLD, UTHR, BIIB
|
13F-HR |
8/14/2024, 04:18 PM |
Q1 2024 |
38 |
$887M |
+$35M |
-$131M |
-$96.5M |
INSM, FOLD, BMRN, BIIB, UTHR
|
13F-HR |
5/15/2024, 04:10 PM |
Q4 2023 |
34 |
$1.1B |
+$86.4M |
-$89.5M |
-$3.07M |
INSM, FOLD, BMRN, BIIB, UTHR
|
Restatement |
2/15/2024, 02:34 PM |
Q3 2023 |
29 |
$1.06B |
+$10.7M |
-$21M |
-$10.2M |
BMRN, INSM, UTHR, FOLD, BIIB
|
13F-HR |
11/14/2023, 04:41 PM |
Q2 2023 |
30 |
$1.24B |
+$40.4M |
-$12.3M |
+$28.2M |
BMRN, UTHR, RVNC, FOLD, INSM
|
13F-HR |
8/14/2023, 04:24 PM |
Q1 2023 |
30 |
$1.21B |
+$18.8M |
-$10.4M |
+$8.35M |
BMRN, RVNC, UTHR, FOLD, BIIB
|
13F-HR |
5/15/2023, 05:06 PM |
Q4 2022 |
29 |
$1.17B |
+$59.8M |
-$156M |
-$96M |
BMRN, UTHR, FOLD, INSM, BIIB
|
13F-HR |
2/14/2023, 04:39 PM |
Q3 2022 |
32 |
$1.26B |
+$3.02M |
-$24.8M |
-$21.8M |
BMRN, UTHR, INSM, ABMD, RVNC
|
13F-HR |
11/14/2022, 04:28 PM |
Q2 2022 |
33 |
$1.15B |
+$22.7K |
-$27.2M |
-$27.2M |
BMRN, UTHR, ABMD, INSM, FOLD
|
13F-HR |
8/15/2022, 05:31 PM |
Q1 2022 |
35 |
$1.29B |
+$7.47M |
-$49.3M |
-$41.8M |
BMRN, ABMD, INSM, UTHR, FOLD
|
13F-HR |
5/16/2022, 04:35 PM |
Q4 2021 |
37 |
$1.56B |
+$54.4M |
-$71.2M |
-$16.8M |
BMRN, ABMD, INSM, UTHR, FOLD
|
13F-HR |
2/14/2022, 04:28 PM |
Q3 2021 |
42 |
$1.66B |
+$28.5M |
-$48.2M |
-$19.7M |
ABMD, BMRN, INSM, STAA, UTHR
|
13F-HR |
11/15/2021, 04:19 PM |
Q2 2021 |
42 |
$1.81B |
+$25.7M |
-$110M |
-$83.9M |
STAA, BMRN, ABMD, INSM, BIIB
|
13F-HR |
8/16/2021, 04:36 PM |
Q1 2021 |
42 |
$1.76B |
+$144M |
-$192M |
-$47.4M |
INSM, STAA, ABMD, BMRN, UTHR
|
13F-HR |
5/17/2021, 04:37 PM |
Q4 2020 |
41 |
$1.91B |
+$224M |
-$448M |
-$224M |
STAA, INSM, BMRN, FOLD, ABMD
|
13F-HR |
2/16/2021, 04:33 PM |
Q3 2020 |
43 |
$1.82B |
+$140M |
-$202M |
-$61.4M |
IMMU, INSM, STAA, ABMD, BMRN
|
13F-HR |
11/16/2020, 04:23 PM |
Q2 2020 |
41 |
$1.66B |
+$40.7M |
-$111M |
-$70.1M |
IMMU, STAA, BMRN, INSM, ABMD
|
13F-HR |
8/14/2020, 04:15 PM |
Q1 2020 |
37 |
$1.19B |
+$10.4M |
-$265M |
-$255M |
BMRN, STAA, INSM, EPZM, UTHR
|
13F-HR |
5/15/2020, 04:09 PM |
Q4 2019 |
37 |
$1.82B |
+$8.66M |
-$166M |
-$157M |
BMRN, INSM, EPZM, STAA, IMMU
|
Restatement |
4/8/2020, 04:35 PM |
Q3 2019 |
37 |
$1.5B |
$0 |
-$199M |
-$199M |
BMRN, INSM, ABMD, UTHR, STAA
|
13F-HR |
11/14/2019, 04:14 PM |
Q2 2019 |
39 |
$2.06B |
+$22.7M |
-$71.8M |
-$49.1M |
BMRN, INSM, ABMD, SAGE, ALXN
|
13F-HR |
8/14/2019, 04:17 PM |
Q1 2019 |
37 |
$2.4B |
+$138M |
-$33.5M |
+$105M |
BMRN, INSM, ABMD, UTHR, ALXN
|
Restatement |
7/30/2019, 12:25 PM |
Q4 2018 |
36 |
$1.88B |
+$78.5M |
-$32.2M |
+$46.3M |
ABMD, BMRN, UTHR, STAA, ALXN
|
13F-HR |
2/14/2019, 04:25 PM |
Q3 2018 |
36 |
$2.47B |
+$25M |
-$96.8M |
-$71.8M |
ABMD, BMRN, UTHR, STAA, ALXN
|
13F-HR |
11/14/2018, 04:29 PM |
Q2 2018 |
36 |
$2.5B |
+$77.1M |
-$198M |
-$121M |
ABMD, BMRN, CLVSQ, UTHR, INSM
|
13F-HR |
8/14/2018, 04:28 PM |
Q1 2018 |
36 |
$2.34B |
+$84.4M |
-$86.8M |
-$2.43M |
ABMD, CLVSQ, BMRN, UTHR, INSM
|
13F-HR |
5/15/2018, 04:28 PM |
Q4 2017 |
37 |
$2.32B |
+$89.5M |
-$130M |
-$40.2M |
ABMD, UTHR, CLVSQ, BMRN, INSM
|
13F-HR |
2/14/2018, 05:00 PM |
Q3 2017 |
40 |
$2.37B |
+$60.1M |
-$53.5M |
+$6.61M |
ABMD, CLVSQ, BMRN, UTHR, INSM
|
13F-HR |
11/14/2017, 04:40 PM |
Q2 2017 |
38 |
$2.14B |
+$54.8M |
-$176M |
-$121M |
CLVSQ, ABMD, UTHR, BMRN, ALXN
|
13F-HR |
8/14/2017, 04:41 PM |
Q1 2017 |
39 |
$2.12B |
+$207M |
-$33.4M |
+$173M |
UTHR, CLVSQ, ABMD, BMRN, ALXN
|
13F-HR |
5/15/2017, 04:33 PM |
Q4 2016 |
38 |
$1.75B |
+$95.5M |
-$32.5M |
+$62.9M |
UTHR, ABMD, CLVSQ, BMRN, AMAG
|
13F-HR |
2/14/2017, 05:36 PM |
Q3 2016 |
42 |
$1.72B |
+$99.5M |
-$73.7M |
+$25.9M |
ABMD, UTHR, BMRN, CLVSQ, AMAG
|
13F-HR |
11/14/2016, 04:49 PM |
Q2 2016 |
45 |
$1.32B |
+$227M |
-$162M |
+$65M |
ABMD, UTHR, BMRN, AMAG, CLVSQ
|
Restatement |
8/15/2016, 05:46 PM |
Q1 2016 |
44 |
$1.29B |
+$21.6M |
-$55.5M |
-$34M |
ABMD, UTHR, ANAC, BMRN, AMAG
|
13F-HR |
5/16/2016, 05:15 PM |
Q4 2015 |
43 |
$1.8B |
+$138M |
-$242M |
-$105M |
ABMD, ANAC, UTHR, BMRN, CLVSQ
|
13F-HR |
2/16/2016, 05:00 PM |
Q3 2015 |
47 |
$2.08B |
+$185M |
-$252M |
-$67.1M |
ANAC, CLVSQ, ABMD, UTHR, BMRN
|
13F-HR |
11/16/2015, 04:28 PM |
Q2 2015 |
45 |
$2.25B |
+$80.5M |
-$64.5M |
+$16M |
UTHR, ANAC, BMRN, CLVSQ, ABMD
|
13F-HR |
8/14/2015, 04:36 PM |
Q1 2015 |
46 |
$2.02B |
+$372M |
-$441M |
-$68.7M |
UTHR, BMRN, ANAC, ABMD, CLVSQ
|
13F-HR |
5/15/2015, 05:11 PM |
Q4 2014 |
46 |
$1.7B |
+$177M |
-$89.7M |
+$87.2M |
UTHR, AUXL, CBST, CLVSQ, BMRN
|
13F-HR |
2/17/2015, 05:18 PM |
Q3 2014 |
43 |
$1.34B |
+$235M |
-$281M |
-$45.7M |
UTHR, AUXL, CBST, BMRN, CYBX
|
13F-HR |
11/13/2014, 02:40 PM |
Q2 2014 |
42 |
$1.34B |
+$203M |
-$82.4M |
+$121M |
ITMN, UTHR, CYBX, CBST, AUXL
|
13F-HR |
8/13/2014, 07:45 PM |
Q1 2014 |
39 |
$1.21B |
$0 |
$0 |
|
ITMN, AUXL, CYBX, UTHR, CBST
|
New Holdings |
5/15/2014, 06:36 PM |
Q1 2014 |
39 |
$1.21B |
+$60.9M |
-$60.6M |
+$290K |
ITMN, AUXL, CYBX, UTHR, CBST
|
13F-HR |
5/15/2014, 04:46 PM |
Q4 2013 |
34 |
$1.07B |
$0 |
$0 |
|
CYBX, UTHR, AUXL, CBST, ABMD
|
13F-HR |
2/13/2014, 05:04 PM |